UBS Group’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
|
|||||
|
2025
Q1 | $8.64K | Sell |
|
|||||
|
2024
Q4 | $28.7K | Sell |
|
|||||
|
2024
Q3 | $24.6K | Buy |
|
|||||
|
2024
Q2 | – | Hold |
|
|||||
|
2024
Q1 | – | Hold |
|
|||||
|
2023
Q4 | – | Hold |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $5.93K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $2.31K | Sell |
|
|||||
|
2022
Q3 | $7K | Buy |
|
|||||
|
2022
Q2 | $1K | Sell |
|
|||||
|
2022
Q1 | $23K | Sell |
|
|||||
|
2021
Q4 | $26K | Buy |
|
|||||
|
2021
Q3 | $24K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $393K | Buy |
|
|||||
|
2020
Q4 | – | Hold |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $13K | Sell |
|
|||||
|
2020
Q1 | $34K | Buy |
|
|||||
|
2019
Q4 | $0 | Sell |
|
|||||
|
2019
Q3 | $12K | Buy |
|
|||||
|
2019
Q2 | $0 | Sell |
|
|||||
|
2019
Q1 | $2K | Sell |
|
|||||
|
2018
Q4 | $13K | Buy |
|
|||||
|
2018
Q3 | $2K | Sell |
|
|||||
|
2018
Q2 | $39K | Sell |
|
|||||
|
2018
Q1 | $69K | Buy |
|
|||||
|
2017
Q4 | $88K | Sell |
|
|||||
|
2017
Q3 | $267K | Buy |
|
|||||
|
2017
Q2 | $117K | Sell |
|
|||||
|
2017
Q1 | $135K | Buy |
|
|||||
|
2016
Q4 | $148K | Buy |
|
|||||
|
2016
Q3 | $243K | Hold |
|
|||||
|
2016
Q2 | $255K | Sell |
|
|||||
|
2016
Q1 | $680K | Buy |
|
|||||
|
2015
Q4 | $138K | Buy |
|
|||||
|
2015
Q3 | $118K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $14K | Sell |
|
|||||
|
2014
Q4 | $21K | Buy |
|